US OptionsDetailed Quotes
ELAN250117C22000
- 0.05
- 0.000.00%
15min DelayClose Jan 17 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume138 Open Interest22.00Strike Price0.00Turnover0.00%IV83.44%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma240.40Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Elanco Animal Health Stock Discussion
Sign in to post a comment
$Elanco Animal Health (ELAN.US)$Barclays Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Raises Target Price to $20
1
$Elanco Animal Health (ELAN.US)$Is Elanco Animal Health (ELAN) The Best Pet Stock To Invest In According To Analysts?
1
$Elanco Animal Health (ELAN.US)$Elanco Animal Health Is Maintained at Overweight by Barclays
$Elanco Animal Health (ELAN.US)$Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?
1
$Elanco Animal Health (ELAN.US)$We Might See A Profit From Elanco Animal Health Incorporated (NYSE:ELAN) Soon
1
$Elanco Animal Health (ELAN.US)$How Elanco Animal Health Incorporated (ELAN) is the Best Small-Cap Value Stock to Buy According to Hedge Funds
1
$Elanco Animal Health (ELAN.US)$BofA Securities Maintains Elanco Animal Health(ELAN.US) With Buy Rating
1
$Elanco Animal Health (ELAN.US)$New Data Reveals Elanco's Canine Parvovirus Monoclonal Antibody Treatment Significantly Improves Puppy Survival Rates and Relieves Operational Stress in Veterinary Clinics
1
$Elanco Animal Health (ELAN.US)$ Reuters
3 mins ago
Elanco Receives FDA Approval for Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets), the Broadest(I) Canine Oral Parasiticide Protection in a Single Monthly Dose
3 mins ago
Elanco Receives FDA Approval for Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets), the Broadest(I) Canine Oral Parasiticide Protection in a Single Monthly Dose
1
8
No comment yet
Lnova : important info, tyvm for sharing
Stock_Drift OP Lnova : TY. appreciate it.